PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21245169-8	2011	Recruitment of BRCA1 to the p53-binding region of the p21 promoter in response to DNA damage required methylation of Arg 754 of p300 by CARM1.	Arginine	117-120	BRCA1 DNA repair associated	Homo sapiens	15-20	
32356124-13	2020	Online protein structure predictions revealed that BRCA1 (3326A>T) mutations mutated AGA at this site to TGA resulting in a translated Arg (arginine) mutation as a stop codon, while BRCA2 (1342A>C) mutated AAT at this site to CAT resulting in a translated Asn mutation to His.	Arginine	135-138	BRCA1 DNA repair associated	Homo sapiens	51-56	
32356124-13	2020	Online protein structure predictions revealed that BRCA1 (3326A>T) mutations mutated AGA at this site to TGA resulting in a translated Arg (arginine) mutation as a stop codon, while BRCA2 (1342A>C) mutated AAT at this site to CAT resulting in a translated Asn mutation to His.	Arginine	140-148	BRCA1 DNA repair associated	Homo sapiens	51-56	
30430339-5	2019	Additionally, bioinformatics analysis showed that BRCA2-tryptophan > arginine substitutions result in altered interaction of BRCA1/PALB2/BRCA2/protein complex and impaired HDDR pathway.	Arginine	72-80	BRCA1 DNA repair associated	Homo sapiens	128-133	
11782367-7	2002	Transient expression of dominant-negative p53 ((175)Arg-->His) counteracted the detrimental effects of BPDE on BRCA-1 promoter activity and protein levels.	Arginine	52-55	BRCA1 DNA repair associated	Homo sapiens	114-120	
16049003-4	2005	By a comparison with the structure of the BRCA1 BRCT bound to a phosphopeptide, we suggest that two arginine residues in MDC1, Arg(1932) and Arg(1933) may recognize the COOH terminus of the peptide as well as the penultimate Glu of H2AX, while Gln(2013) may provide additional specificity for the COOH-terminal Tyr.	Arginine	100-108	BRCA1 DNA repair associated	Homo sapiens	42-47	
16049003-4	2005	By a comparison with the structure of the BRCA1 BRCT bound to a phosphopeptide, we suggest that two arginine residues in MDC1, Arg(1932) and Arg(1933) may recognize the COOH terminus of the peptide as well as the penultimate Glu of H2AX, while Gln(2013) may provide additional specificity for the COOH-terminal Tyr.	Arginine	127-130	BRCA1 DNA repair associated	Homo sapiens	42-47	
16049003-4	2005	By a comparison with the structure of the BRCA1 BRCT bound to a phosphopeptide, we suggest that two arginine residues in MDC1, Arg(1932) and Arg(1933) may recognize the COOH terminus of the peptide as well as the penultimate Glu of H2AX, while Gln(2013) may provide additional specificity for the COOH-terminal Tyr.	Arginine	141-144	BRCA1 DNA repair associated	Homo sapiens	42-47	
14576432-4	2003	These findings provide a molecular basis for BRCT domain function in the DNA damage response and may help to explain why the BRCA1 BRCT domain mutation Met1775 --> Arg, which fails to bind phosphopeptides, predisposes women to breast and ovarian cancer.	Arginine	167-170	BRCA1 DNA repair associated	Homo sapiens	125-130	
20614009-5	2010	METHODS/PRINCIPAL FINDINGS: Here we demonstrate for the first time that BRCA1 is methylated both in breast cancer cell lines and breast cancer tumor samples at arginine and lysine residues through immunoprecipitation and western blot analysis.	Arginine	160-168	BRCA1 DNA repair associated	Homo sapiens	72-77	
20159462-4	2010	Crystal structures of BRCA1 and MDC1 bound to tetrapeptide substrates reveal differences in the environment of conserved arginines (Arg1699 in BRCA1 and Arg1933 in MDC1) that determine the relative affinity for peptides with -COO(-) versus -CO-NH(2) termini.	Arginine	121-130	BRCA1 DNA repair associated	Homo sapiens	22-27	
20159462-4	2010	Crystal structures of BRCA1 and MDC1 bound to tetrapeptide substrates reveal differences in the environment of conserved arginines (Arg1699 in BRCA1 and Arg1933 in MDC1) that determine the relative affinity for peptides with -COO(-) versus -CO-NH(2) termini.	Arginine	121-130	BRCA1 DNA repair associated	Homo sapiens	143-148